Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
2022 · Neurotherapeutics · 158 citations
https://doi.org/10.1007/s13311-022-01237-4
A
Adele A. Mitchell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
1.9K
Citations
20
h-index
29
i10-index
Adele A. Mitchell is an academic researcher from Biogen (United States). The author has contributed to research in topics: Genetic Associations and Epidemiology & Genomics and Rare Diseases & Migraine and Headache Studies. The author has an h-index of 20, co-authored 34 publications.
Papers by this author
worksEvaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study
2011 · BMC Medical Genetics · 47 citations
https://doi.org/10.1186/1471-2350-12-63
Genetic map of regional sulcal morphology in the human brain from UK biobank data
2022 · Nature Communications · 27 citations
https://doi.org/10.1038/s41467-022-33829-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat